TFPI2 and neoplasm: This observation presents a paradox: while TFPI2 downregulation in tumor cells is linked to cancer progression and poor prognosis [15], elevated systemic TFPI2 concentrations also appear to be associated with unfavorable clinical outcomes in select cancers.